跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,719 条关于
“IRAK1/4”
全部
18,719
临床试验
7,119
药物
4,454
机构
1,600
资讯
5,546
去年
KME-0584: Novel IRAK1/4 Inhibitor Shows Promise in AML and HR-MDS Treatment
11个月前
Rigel Pharmaceuticals Advances R289 Phase 1b Trial for Lower-Risk MDS with First Dose Expansion Patient
9个月前
Rigel's R289 Shows Promise in Lower-Risk MDS with 33% Transfusion Independence Rate at ASH 2025
去年
FDA Grants Fast Track Designation to Rigel's R289 for Lower-Risk Myelodysplastic Syndrome
去年
Rigel Pharmaceuticals Reports Strong Growth with TAVALISSE and REZLIDHIA in 2024, Expands Global Reach
2个月前
Rigel Pharmaceuticals Appoints Board Member Alison L. Hannah, M.D. as Chief Medical Officer to Drive Oncology Pipeline
去年
BlueRock Therapeutics' Cell Therapy Bemdaneprocel Shows Positive 24-Month Data in Parkinson's Disease
去年
CAR-T Therapy Demonstrates Significant Reduction in Multiple Myeloma Disease Burden
去年
Fall Clinical 2024 Highlights Advances in Acne, Psoriasis, Atopic Dermatitis, and Aesthetic Dermatology
去年
AAO 2024 Highlights: Aging Clinicians, Presbyopia Drop, Modern Anesthesia, and AMD Advancements
第 1 页,共 555 页
上一页
下一页